FPI |
Rat |
Twice daily 10 mg/kg P7C3–A20 IP 30 min post TBI for 7 days |
Decreased contusion volume; protected pericontusional mature neurons; augmented adult hippocampal neurogenesis; improved neurobehavioral outcomes |
Blaya et al., 2014 |
FPI |
Rat |
Twice daily 10 mg/kg P7C3–A20 IP 30 min or 3 hr post TBI for 7 days |
Preserved injury-induced reduction in LTP |
Unpublished |
CCI |
Mouse |
Twice daily 10 mg/kg P7C3–A20 IP 30 min post TBI for 7 days |
Increased early-stage adult hippocampal neurogenesis |
Unpublished |
Blast |
Mouse |
3, 10, and 30 mg/kg/day P7C3–S243 IP or oral 24 hrs post TBI for 11 days |
Blocked axonal degeneration in brain; improved learning, memory, motor coordination; preserved synaptic plasticity |
Yin et al, 2014 |
FPI |
Rat |
Twice daily 10 mg/kg P7C3–A20 IP 30 min post TBI for 7 days |
Reduced reactive phenotype of activated microglia, macrophages, astrocytes (qualitative) |
Unpublished |